Terns Pharmaceuticals, Inc.
TERN
$52.63
$0.070.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -96.21M | -94.44M | -91.75M | -90.39M | -88.85M |
| Total Depreciation and Amortization | 501.00K | 602.00K | 697.00K | 829.00K | 896.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.85M | 12.77M | 13.20M | 14.02M | 13.56M |
| Change in Net Operating Assets | -321.00K | 3.39M | 3.49M | 3.89M | 4.38M |
| Cash from Operations | -82.18M | -77.68M | -74.36M | -71.66M | -70.02M |
| Capital Expenditure | -- | 0.00 | 0.00 | -13.00K | -42.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -298.04M | -42.39M | -35.14M | -18.44M | -12.37M |
| Cash from Investing | -298.04M | -42.39M | -35.14M | -18.45M | -12.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 743.75M | 1.02M | 164.38M | 164.46M | 164.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -235.00K | -319.00K | -394.00K | -394.00K | -388.00K |
| Cash from Financing | 743.51M | 696.00K | 163.99M | 164.06M | 164.00M |
| Foreign Exchange rate Adjustments | 16.00K | -68.00K | -20.00K | -33.00K | -56.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 363.31M | -119.44M | 54.47M | 73.92M | 81.51M |